Previous studies have shown that bortezomib induces nuclear translocation of IkBa resulting in gene-specific suppression of NF-kB–dependent transcription and induction of apoptosis in CTCL [36, 37]. This evidence concerns the gene NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma.